News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
Ketamine One Launching Two Inaugural Research Studies
Wellbeing Digital Sciences
Cybin: Video Profile
Cybin Inc.
Pasithea Therapeutics Opens its First Ketamine Therapy Clinic in the United Kingdom
Pasithea Therapeutics
Blackhawk Growth Appoints New Advisor to Support Expansion into Psychedelics And Mental Health Treatments
MindBio Therapeutics
Braxia Scientific CEO Dr. Roger McIntyre to Share Stage With NBA Champion Lamar Odom and 'Psychedelic Concierge' Zappy Zapolin to Discuss the Benefits of Ketamine Treatment for Mental Health
Braxia Scientific Corp.
Clearmind Medicine Appoints Distinguished Addiction Experts Professor Wim van den Brink and Professor Gabriele Fischer to Its Scientific Advisory Board
Clearmind Medicine
PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome
Pharmather
MindMed Joins Clinical Trials Transformation Initiative
Mind Medicine (MindMed)
Algernon Files Meeting Request with MHRA for Use of DMT in Phase 1/2a Human Stroke Study
Algernon Pharmaceuticals
Clearmind Medicine Files Provisional Patent Application Related to Methods of Drug-Assisted Psychotherapy
Clearmind Medicine
Mark Haden | Scientific Advisory Board, Clearmind
Clearmind Medicine
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.